catalent novo nordisk news

Novo Nordisk says Catalent buyout to close soon

Novo Nordisk says Catalent buyout to close soon as regulatory conditions met

Novo Nordisk (NVO) announced Saturday that its pending acquisition of three Catalent (NYSE:CTLT) production sites is expected to close within days as its parent entity satisfied all regulatory conditions to buy the U.

Business Insider · 1d

Novo says Catalent deal regulatory closing conditions fulfilled

Novo Nordisk (NVO) announced that as of today, all regulatory closing conditions relating to the review of its pending acquisition of Catalent

Reuters on MSN · 1d

Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say

All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. contract drug maker Catalent had been fulfilled, the companies said on Saturday, adding that the transaction is expected to be completed in the coming days.

Bloomberg on MSN · 2d

Novo Nordisk Set to Close Catalent Deal Without FTC Challenge

Novo Nordisk A/S can advance with its acquisition of factories from contract development and manufacturing organization Catalent Inc. after the Federal Trade Commission declined to challenge the deal.

4hon MSN

Novo Nordisk to Invest $1.2 Billion in New Production Facility in Denmark

The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the ...

Indiana Daily Student1d

Novo’s takeover of Catalent set to proceed after FTC declines to challenge deal

Novo Holdings will proceed with its $16.5 billion acquisition of Catalent, the companies announced Saturday, after the ...

DPA International on MSN1d

Ozempic maker Novo Nordisk to boost production through acquisition

Danish pharma company Novo Nordisk, makers of weight-loss drugs Ozempic and Wegovy, plans to expand production based on a ...

Health Care Roundup: Market Talk

Find insight on Novo Holdings, Malaysian glove sector and more in the latest Market Talks covering health care.

Novo Holdings’ acquisition of Catalent gains EC approval

Novo Holdings, the investment arm of the Novo Nordisk Foundation, has gained approval from the European Commission (EC) for ...

devdiscourse7h

Novo Holdings Acquires Catalent: A Deal to Boost Weight-Loss Drug Production

Novo Holdings has completed regulatory conditions for its $16.5 billion acquisition of Catalent, aiming to increase production of Wegovy, a weight-loss drug. The deal includes selling three Catalent ...

Indiana Daily Student11d

What Novo’s takeover of Catalent could mean for Bloomington workers

Years of layoffs and alleged mismanagement have left employees “sick” of the pharmaceutical contract manufacturer Catalent, ...

BioSpace6d

Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts

In the U.S., the chorus of opposition against the proposed buyout continues to grow and now includes the CEOs of Roche and ...

24/7 Wall St2d

Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk to boost production with a new acquisition

Danish pharma giant Novo Nordisk, which makes weight-loss drugs Ozempic and Wegovy, is set to boost production with a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results